Scott Kapnick 13D and 13G filings for Aileron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 07:54 am Sale |
2022-12-31 | 13G | Aileron Therapeutics, Inc. ALRN |
Scott Kapnick | 379,608 8.400% |
-3 (-0.00%) |
Filing |
| 2022-02-14 09:02 am Purchase |
2021-12-31 | 13G | Aileron Therapeutics, Inc. ALRN |
Scott Kapnick | 379,611 8.400% |
210,750 (+124.81%) |
Filing |
| 2020-06-08 5:16 pm Purchase |
2019-04-02 | 13G | Aileron Therapeutics, Inc. ALRN |
Scott Kapnick | 168,861 8.800% |
168,861 (New Position) |
Filing |